128 related articles for article (PubMed ID: 33358282)
1. Radiotherapy for Oropharyngeal Carcinoma With an Uninvolved Contralateral Neck: The Safety of Omission of Contralateral High Level II and Retropharyngeal Lymph Nodes From Elective Target Volumes.
Iyizoba-Ebozue Z; Murray LJ; Ramasamy S; Sen M; Murray P; Cardale K; Dyker K; Prestwich RJD
Clin Oncol (R Coll Radiol); 2021 May; 33(5):331-339. PubMed ID: 33358282
[TBL] [Abstract][Full Text] [Related]
2. Omitting Elective Irradiation of the Contralateral Retropharyngeal Nodes in Oropharyngeal Squamous Cell Carcinoma Treated with Intensity-modulated Radiotherapy.
Nagatsuka M; Hughes RT; Shenker RF; Frizzell BA; Greven KM
Cureus; 2019 Jan; 11(1):e3825. PubMed ID: 30868038
[TBL] [Abstract][Full Text] [Related]
3. Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.
Spencer CR; Gay HA; Haughey BH; Nussenbaum B; Adkins DR; Wildes TM; DeWees TA; Lewis JS; Thorstad WL
Cancer; 2014 Dec; 120(24):3994-4002. PubMed ID: 25143048
[TBL] [Abstract][Full Text] [Related]
4. Incidence and patterns of retropharyngeal lymph node involvement in oropharyngeal carcinoma.
Iyizoba-Ebozue Z; Murray LJ; Arunsingh M; Vaidyanathan S; Scarsbrook AF; Prestwich RJD
Radiother Oncol; 2020 Jan; 142():92-99. PubMed ID: 31431388
[TBL] [Abstract][Full Text] [Related]
5. Sparing of high retropharyngeal nodal basins in patients with unilateral oropharyngeal carcinoma treated with intensity modulated radiation therapy.
Leeman JE; Gutiontov S; Romesser P; McBride S; Riaz N; Lee N; Tsai CJ
Pract Radiat Oncol; 2017; 7(4):254-259. PubMed ID: 28094212
[TBL] [Abstract][Full Text] [Related]
6. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes.
Lin TA; Garden AS; Elhalawani H; Elgohari B; Jethanandani A; Ng SP; Mohamed AS; Frank SJ; Glisson BS; Debnam JM; Sturgis EM; Phan J; Reddy JP; Fuller CD; Morrison WH; Skinner HD; Rosenthal DI; Gunn GB
Cancer; 2019 May; 125(9):1536-1546. PubMed ID: 30620385
[TBL] [Abstract][Full Text] [Related]
7. Pattern of cervical lymph node metastasis in tonsil cancer: predictive factor analysis of contralateral and retropharyngeal lymph node metastasis.
Chung EJ; Oh JI; Choi KY; Lee DJ; Park IS; Kim JH; Rho YS
Oral Oncol; 2011 Aug; 47(8):758-62. PubMed ID: 21680228
[TBL] [Abstract][Full Text] [Related]
8. Retropharyngeal lymph node-sparing radiotherapy in patients with oropharyngeal carcinoma.
Kang BH; Eom KY; Song C; Kim JH; Wu HG; Kim IA; Kim JS
Radiat Oncol J; 2021 Jun; 39(2):99-106. PubMed ID: 34619826
[TBL] [Abstract][Full Text] [Related]
9. The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer.
Gunn GB; Debnam JM; Fuller CD; Morrison WH; Frank SJ; Beadle BM; Sturgis EM; Glisson BS; Phan J; Rosenthal DI; Garden AS
Cancer; 2013 Sep; 119(17):3162-9. PubMed ID: 23733178
[TBL] [Abstract][Full Text] [Related]
10. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
11. Is the retropharyngeal lymph node the first echelon node for carcinoma tonsil? Prospective evaluation and literature review.
Panda S; Thakar A; Kakkar A; Kumar R; Seenu V; Singh CA; Sharma SC
Eur Arch Otorhinolaryngol; 2021 Oct; 278(10):3995-4004. PubMed ID: 33417147
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT.
Tseng JR; Ho TY; Lin CY; Lee LY; Wang HM; Liao CT; Yen TC
PLoS One; 2013; 8(11):e79766. PubMed ID: 24244559
[TBL] [Abstract][Full Text] [Related]
13. Retropharyngeal lymph node metastasis in 54 patients with oropharyngeal squamous cell carcinoma who underwent surgery-based treatment.
Chung EJ; Kim GW; Cho BK; Cho SJ; Yoon DY; Rho YS
Ann Surg Oncol; 2015 Sep; 22(9):3049-54. PubMed ID: 25608771
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET for retropharyngeal lymph node metastasis in oropharyngeal and hypopharyngeal cancers: impact on diagnosis and prediction analysis.
Chan SC; Lin CY; Ng SH; Chang JT; Wang HM; Liao CT; Lo CW; Yen TC
Nucl Med Commun; 2010 Mar; 31(3):260-5. PubMed ID: 20072075
[TBL] [Abstract][Full Text] [Related]
15. Contralateral regional recurrence after elective unilateral neck irradiation in oropharyngeal carcinoma: A literature-based critical review.
Al-Mamgani A; van Werkhoven E; Navran A; Karakullukcu B; Hamming-Vrieze O; Machiels M; van der Velden LA; Vogel WV; Klop WM
Cancer Treat Rev; 2017 Sep; 59():102-108. PubMed ID: 28779635
[TBL] [Abstract][Full Text] [Related]
16. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
[TBL] [Abstract][Full Text] [Related]
17. [Retropharyngeal lymph node dissection in head and neck cancers treated with transoral robotic surgery].
Chen SW; Zhang X; Li JJ; Li H; Yang AK; Zhang Q; Li QL; Chen WK; He LJ; Yang ZY; Song M
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):446-449. PubMed ID: 35615803
[No Abstract] [Full Text] [Related]
18. Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck.
Lim YC; Koo BS; Lee JS; Lim JY; Choi EC
Laryngoscope; 2006 Jul; 116(7):1148-52. PubMed ID: 16826050
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of retropharyngeal nodes dissection in hypopharyngeal cancer].
Xu W; Lyu Z; Zou J; Feng S; Cao H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jul; 49(7):553-7. PubMed ID: 25257269
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
Guan X; Wang X; Liu Y; Hu C; Zhu G
Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
